COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group1: standard treatment (based on the latest National Diagnostic and Treatment Protocol) + warm cupping: retained cupping 4 cm from each side of theT3 vertebrae for 1
with a medium glass with a mouth diameter of 5 cm and a height of 8 cm, so the suction rate is between 10 and 15 mm. Intervention 2: Intervention group2: standard treatment (based on the latest Nation
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients who need hospitalization according to the guidelines of "National guidelines for the diagnosis and treatment of COVID-19" and for whom medical treatment has been initiated. And o2 saturation<93%. Or Chest CT-scan with COVID-19 pattern. Volunteer to join the trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Patients with complications of serious underlying diseases, such as coronary heart disease, chronic obstructive pulmonary disease, obstructive pulmonary disease, meningitis, encephalitis, cirrhosis. Coagulation disorder and platelets<50,000. Probability of pulmonary embolism. Patients with respiratory failure who require mechanical ventilation. Pregnant or lactating women. History of allergies and any skin lesions in the area. Not be volunteer to join the trial and sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood oxygen saturation. Timepoint: Before intervention and 1,2,3,4,5,6,7 days after intervention. Method of measurement: Pulse oximetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of cough. Timepoint: Before intervention and 1?2?3?4?5?6?7 days after intervention. Method of measurement: CTCAE version 5.;Severity of dyspnea. Timepoint: Before intervention and 1?2?3?4?5?6?7 days after intervention. Method of measurement: CTCAE version 5.;Chest pain (non cardiac). Timepoint: Before intervention and 1?2?3?4?5?6?7 days after intervention. Method of measurement: CTCAE version 5.;Need to oxygen therapy. Timepoint: Before intervention and 1?2?3?4?5?6?7 days after intervention. Method of measurement: CTCAE version 5.;Duration of hospital stay. Timepoint: Last day of hospitalization. Method of measurement: Day. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReihane Alipour
Tehran University of Medical Sciences
Outcome results
None listed